Gene Therapy Approaches to Replace or Restore Dystrophin PF-06939926 – Kasia Lobello, MD (Pfizer, Inc.) RGX-202 – Jahannaz Dastgir, DO (REGENXBIO) scAAV9.U7-ACCA – Kevin Flanigan, MD (Nationwide Children’s Hospital) SGT-001 – Carl Morris, PhD (Solid Biosciences) SRP-9001 – Teji Singh, MD (Sarepta Therapeutics) 2022 PPMD Annual Conference,Conferences & Meetings 2 years ago You may also like 59:37 Research Row Breakout Session: Approved or on the Horizon – PPMD 2023 Annual Conference 1 year ago 2023 PPMD Annual Conference,Conferences & Meetings 59:48 Research Row Breakout Session: Impacting Downstream – PPMD 2023 Annual Conference 1 year ago 2023 PPMD Annual Conference,Conferences & Meetings 59:13 Research Row Breakout Session: Exon Skipping Strategies – PPMD 2023 Annual Conference 1 year ago 2023 PPMD Annual Conference,Conferences & Meetings 37:48 Advancements in Cell & Gene Therapy – PPMD 2023 Annual Conference 1 year ago 2023 PPMD Annual Conference,Conferences & Meetings 2:12:40 Gene Therapy Town Hall – PPMD 2023 Annual Conference 1 year ago 2023 PPMD Annual Conference,Conferences & Meetings 34:56 Keynote: Change How You See, See How You Change – PPMD 2023 Annual Conference 1 year ago 2023 PPMD Annual Conference,Conferences & Meetings 36:32 Keynote: Priorities or Finding Your “US” – PPMD 2023 Annual Conference 1 year ago 2023 PPMD Annual Conference,Conferences & Meetings 18:50 Duchenne Landscape Now Research & Trials Progress – PPMD 2023 Annual Conference 1 year ago 2023 PPMD Annual Conference,Conferences & Meetings «1…45678…25»Page 6 of 25
by: Parent Project Muscular Dystrophy
